What is Tianjin Lisheng Pharmaceutical Co.,Ltd.'s (002393.SZ) StockRank?

MoatMap's StockRank for Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) is 89/100, with a Strong Buy signal. This is a composite score combining Quality (66), Value (70), and Momentum (42) factor ranks across MoatMap's 20,000+ stock universe.

Does Tianjin Lisheng Pharmaceutical Co.,Ltd. have an economic moat?

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Tianjin Lisheng Pharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Tianjin Lisheng Pharmaceutical Co.,Ltd. in?

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002393.SZ

STRONG BUYREMOVE

Tianjin Lisheng Pharmaceutical Co.,Ltd. · Healthcare · China · $679M · Avg Vol: $5M/d

StockRank

P/E (TTM)

10.7x

ROE

8.9%

D/E

0.0x

Dividend %

5.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Tianjin Lisheng is a generic drug manufacturer with thin margins and high input costs, making it a casualty of the shifting pricing power toward high-moat CDMOs and validated innovators.

COMPANY DESCRIPTION

Tianjin Lisheng Pharmaceutical Co., Ltd. manufactures and distributes a wide range of chemical generic drugs, active pharmaceutical ingredients (APIs), and traditional Chinese medicines, with a focus on cardiovascular and endocrine therapies. The company maintains a stable market position in China's domestic healthcare system through its extensive product portfolio and participation in national volume-based procurement programs. Its established manufacturing facilities and strict quality control standards support its role as a reliable, high-volume drug supplier.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	169M	170M	197M	206M	6.7%
EPS	0.04	0.17	0.09	0.20	64.4%
Shares	309M	310M	309M	309M	+0.0%
Debt	7M	5M	8M	7M	0.3%
Equity	643M	725M	705M	684M	2.1%
Op CF	49M	30M	13M	37M	-9.3%
Inv CF	-23M	3M	-38M	-25M	—
Fin CF	-5M	-7M	-26M	-20M	—

PRICE (1M)-14.2%

SMA 50SMA 200

$2.09

RSI (14)

35.3

52W High

$3.38

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

9.5%71.8

ROE

8.9%69.0

GP/Assets

12.9%31.6

Op. Margin

15.5%75.7

FCF/Assets

4.9%70.0

Piotroski

—55.7

Int. Cover

50.0x91.5

D/E Ratio

0.01x88.9

Current Ratio

4.52x67.5

Value

P/E (TTM)

10.7x86.6

EV/EBITDA

11.2x38.7

P/FCF

114.6x66.1

P/B

1.0x79.7

P/S

3.3x54.4

Div Yield

5.3%92.2

Momentum

52W High %

62%43.4

RS 6M

-22%54.2

SMA 50/200

0.93x43.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-6%35.7

FUNDAMENTALS

Market Cap

$679M

P/E (Forward)

—

Gross Margin

52.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002393.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002393.SZ	Tianjin Lisheng Pharmaceutical Co.,Ltd.(you)	$679M	89	STRONG BUY
600976.SS	Jianmin Pharmaceutical Group Co.,Ltd.	$690M	89	STRONG BUY
9989.HK	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$773M	92	STRONG BUY
002349.SZ	Jinghua Pharmaceutical Group Co., Ltd.	$866M	85	STRONG BUY
603676.SS	Tibet Weixinkang Medicine Co., Ltd.	$594M	83	STRONG BUY
0719.HK	Shandong Xinhua Pharmaceutical Company Limited	$533M	84	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd	$1.1B	88	STRONG BUY
600351.SS	Yabao Pharmaceutical Group Co., Ltd	$650M	99	STRONG BUY
000915.SZ	Shandong Wit Dyne Health Co.,Ltd.	$946M	96	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) — Stock Score Summary

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) has a MoatMap StockRank of 89/100 based on Quality (66/100), Value (70/100), and Momentum (42/100) factor scores. The current signal is STRONG BUY. Tianjin Lisheng is a generic drug manufacturer with thin margins and high input costs, making it a casualty of the shifting pricing power toward high-moat CDMOs and validated innovators.

Key Financial Metrics

Price	$2.09
Market Cap	$679M
P/E (TTM)	10.69
Price/Book	0.97
Return on Equity	8.9%
Return on Invested Capital	9.5%
Debt/Equity	0.95
Gross Margin	52.9%
Operating Margin	15.5%
Revenue Growth	-10.2%
Dividend Yield	5.3%
Free Cash Flow	$6M

Tianjin Lisheng Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tianjin Lisheng Pharmaceutical Co.,Ltd.’s (002393.SZ) StockRank?: MoatMap’s StockRank for Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) is 89/100, with a Strong Buy signal. It is a composite of Quality (66), Value (70), and Momentum (42) factor ranks across MoatMap’s 20,000+ stock universe.
Does Tianjin Lisheng Pharmaceutical Co.,Ltd. have an economic moat?: Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tianjin Lisheng Pharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tianjin Lisheng Pharmaceutical Co.,Ltd. in?: Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).